title: Fighting against hematological malignancy in China: from unique system to global impact.
abstract: During recent decades, substantial progress has been made in clinical strategies for treating hematological malignancies. Not only did China benefit from the global progression in the management of acute promyelocytic leukemia, risk-stratification-directed strategies for acute or chronic leukemia and haploidentical hematopoietic stem cell transplantation, the unique system developed by Chinese doctors has also become inspiration for refining global clinical practice. The multicenter trials and collaborations adhering to international standards might further strengthen the global impact and lead the way in specific fields of research worldwide.
authors.affiliation: Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, 100044, China.|Peking-Tsinghua Center for Life Sciences, Beijing, 100087, China.
authors.forename: Meng
authors.initials: M
authors.lastname: Lv
authors.affiliation: Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, 100044, China. huangxiaojun@bjmu.edu.cn.|Peking-Tsinghua Center for Life Sciences, Beijing, 100087, China. huangxiaojun@bjmu.edu.cn.
authors.forename: XiaoJun
authors.initials: X
authors.lastname: Huang
mesh_terms: D002681:China; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data*; D014943:Global Health; D019337:Hematologic Neoplasms / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006650:Histocompatibility Testing; D006801:Humans; D015337:Multicenter Studies as Topic / Q000706:statistics & numerical data*; D017063:Outcome Assessment, Health Care / Q000706:statistics & numerical data; D016019:Survival Analysis
keywords: acute myeloid leukemia; acute promyelocytic leukemia; chronic myeloid leukemia; haploidentical hematopoietic stem cell transplantation; hematological malignancy